Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Non-small Cell Lung Cancer (NSCLC) · Colorectal Cancer (CRC) · Pancreatic Ductal Adenocarcinoma (PDAC) · Advanced Solid Tumors

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

UC Irvine/Chao Family Comprehensive Cancer Center, Orange, California, United States
UCLA, Santa Monica, California, United States
Moffitt Cancer Center, Tampa, Florida, United States
Piedmont Healthcare, Atlanta, Georgia, United States
Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States
Johns Hopkins University, Baltimore, Maryland, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Perlmutter Cancer Center at NYU Langone Health, New York, New York, United States
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Columbia University, New York, New York, United States
Christ Hospital Cancer Center, Cincinnati, Ohio, United States
Taylor Cancer Research Center, Maumee, Ohio, United States
Tennessee Oncology, Chattanooga, Tennessee, United States
Sarah Cannon Research Institute, Nashville, Tennessee, United States
University of Texas at Austin, Austin, Texas, United States
Mary Crowley Cancer Research, Dallas, Texas, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Next Oncology, San Antonio, Texas, United States
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Next Oncology Virginia, Fairfax, Virginia, United States
Virginia Mason Medical Center, Seattle, Washington, United States

מובילי המחקר